CORZ — Core Scientific Cashflow Statement
0.000.00%
Last trade - 00:00- $4.75bn
- $5.50bn
- $319.02m
Annual cashflow statement for Core Scientific, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 47.3 | -2,146 | -246 | -1,315 | -289 |
| Depreciation | |||||
| Non-Cash Items | -87.9 | 1,648 | -335 | 1,272 | -26.6 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -49.5 | 479 | 551 | -27.6 | 525 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -56.7 | 205 | 65.1 | 42.9 | 278 |
| Capital Expenditures | -424 | -602 | -17 | -95.2 | -729 |
| Purchase of Fixed Assets | |||||
| Software Development Costs | |||||
| Other Investing Cash Flow Items | 0.645 | 10.9 | 14 | 0 | -11.8 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -424 | -591 | -3 | -95.2 | -741 |
| Financing Cash Flow Items | -10.7 | 163 | 0 | -7.24 | -32.2 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 604 | 306 | -44.6 | 820 | -63.1 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 123 | -79.4 | 17.5 | 767 | -526 |